Latest News
Yale Cancer Center (YCC) scientists presented research at the 61st annual American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
- September 16, 2019
The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).
- September 13, 2019
Roy H. Decker, M.D., Ph.D., has been named Associate Cancer Center Director for Clinical Services at Yale Cancer Center.
- September 10, 2019
Yale - ASTRO 2019 Schedule of Presentations
- August 22, 2019
A team of investigators at Yale Cancer Center (YCC) have found a major chink in the armor of an incurable childhood brain cancer called Diffuse Intrinsic Pontine Gliomas (DIPG).
- July 01, 2019
“It’s an alarming trend,” says Skyler Johnson, MD. “Some patients choose to forego or delay cancer treatments that have been proven to prolong life and/or cure their cancer, in favor of unproven therapies.”
- June 28, 2019
Smilow Welcomes Two New Radiation Oncologists to Greenwich Hospital
- June 17, 2019
The Amgen Scholars Program at Yale is a partnership between the Amgen Foundation and the Yale School of Medicine MD-PhD and Biological and Biomedical Sciences PhD programs. The goal of the program is to recruit students from under-represented groups to biomedical careers and help them succeed as scientists or physican-scientists.
- June 14, 2019
Connecticut Magazine’s 2019 “Best Doctors” list includes 217 Yale Medicine physicians in 50 specialties who were selected by their peers as the best in their fields.
- June 05, 2019
James B. Yu, MD, associate professor, therapeutic oncology, director, Prostate and Genitourinary Cancer Radiotherapy Program, Yale Cancer Center, discusses drawbacks of radiation therapy in prostate cancer.
